{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:00:35Z","timestamp":1761181235308,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jbspin.2020.04.002","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T21:43:12Z","timestamp":1588542192000},"page":"509-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Panniculitis following baricitinib initiation for treatment of rheumatoid arthritis"],"prefix":"10.1016","volume":"87","author":[{"given":"Alice","family":"Fike","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhett","family":"Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Biehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2020.04.002_bib0030","unstructured":"Olumiant product information, European public assessment report. European Medicines Agency. [Internet. Accessed February 11, 2020]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/olumiant#authorisation-details-section."},{"key":"10.1016\/j.jbspin.2020.04.002_bib0035","unstructured":"Olumiant product information. Eli Lilly and Company. Indianapolis, IN 46285. Issued May 2018. [Internet. Accessed January 21, 2020]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/207924Orig1s000lbl.pdf."},{"key":"10.1016\/j.jbspin.2020.04.002_bib0040","unstructured":"ClinicalTrials.gov. Baricitinib. [Internet. Accessed January 21, 2020]. Available from: https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=baricitinib&cntry=&state=&city=&dist=."},{"key":"10.1016\/j.jbspin.2020.04.002_bib0045","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jbspin.2020.04.002_bib0050","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1136\/annrheumdis-2018-eular.4192","article-title":"Nodular polyarteritis as an unforeseeable adverse reaction in RA patient treated with tofacitinib [abstract]","volume":"77","author":"Muraviev","year":"2018","journal-title":"Ann Rheum Dis Suppl"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X2030066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X2030066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:26:47Z","timestamp":1761150407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X2030066X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1297319X2030066X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2020.04.002","relation":{},"ISSN":["1297-319X"],"issn-type":[{"type":"print","value":"1297-319X"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Panniculitis following baricitinib initiation for treatment of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2020.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie.","name":"copyright","label":"Copyright"}]}}